Tele-Diab: Electronic Diary for Patients With Type 2 Diabetes Mellitus
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Diabetes Mellitus Type 2
- Sponsor
- Medical University of Vienna
- Enrollment
- 50
- Locations
- 1
- Primary Endpoint
- System availability, acceptance, transmission rate
- Last Updated
- 14 years ago
Overview
Brief Summary
The purpose of the study is to show if telemonitoring and automated feedback regarding glucose management, physical activity, blood pressure, and body weight improves treatment of patients with insulin dependent Type 2 Diabetes mellitus.
Detailed Description
In this clinical trial 50 patients with insulin dependent type 2 diabetes will be randomised in two study arms: monitoring of blood glucose and blood pressure using a telemedical device or in an arm with treatment as usual. Patients will the following measurement devices: blood glucose, blood pressure. Both devices can communicate with a mobile phone, which will also be provided to the patients. The mobile phone will transfer the data to a central, safe server. Patients will receive automated reminder/feedback. Caregivers can evaluate the transferred data whenever necessary via a web-based access. Data will be presented in tables as well as trend figures.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Diabetes mellitus Type 2, age 18-70 years, able to use a mobile phone
Exclusion Criteria
- •Pacemaker, intracardial defibrillator, no cure planned within the active study period.
Outcomes
Primary Outcomes
System availability, acceptance, transmission rate
Time Frame: 3 months
Secondary Outcomes
- HbA1c(3 months)